Radioactive Iodine Therapy

Introduction

If your doctor has spoken to you about radioactive iodine (RAI) therapy, you are probably weighing it as the next step in treating an overactive thyroid, a thyroid nodule that is producing too much hormone, or differentiated thyroid cancer after surgery. The word “radioactive” can sound frightening, but RAI therapy is one of the oldest and most studied treatments in nuclear medicine, and its mechanism is unusually precise.

This article explains what RAI therapy is, the conditions it is used to treat, how doctors decide who is a suitable candidate, what alternatives exist, how the treatment is given, what recovery looks like, and what life is like afterwards. It is written for adults who already have a diagnosis and are now planning treatment. A separate section covers RAI therapy in children, since the considerations there are different.

What Is Radioactive Iodine (RAI) Therapy?

Radioactive iodine therapy — often shortened to RAI therapy — is a treatment that uses a radioactive form of iodine called iodine-131 (I-131) to destroy abnormal thyroid cells from inside the body. It is taken by mouth, usually as a capsule, sometimes as a liquid.

The thyroid is a small, butterfly-shaped gland at the front of the neck. It is almost the only tissue in the body that takes up iodine in significant amounts, because it uses iodine to make thyroid hormones (T3 and T4). When you swallow radioactive iodine, the thyroid absorbs it the same way it would absorb iodine from food. Once inside thyroid cells, the I-131 emits a short-range form of radiation (beta radiation) that damages and gradually destroys those cells over weeks to months. Because the radiation only travels a very short distance inside tissue, most of the rest of the body is spared.

This is what distinguishes RAI therapy from external beam radiation, which is delivered from a machine outside the body. RAI works from within, and it works because of the thyroid’s natural appetite for iodine.

RAI therapy has been used for more than seven decades and is endorsed in major thyroid society guidelines, including those of the American Thyroid Association (ATA) and the European Thyroid Association (ETA), as one of the established treatment options for several thyroid conditions.

Why Is RAI Therapy Performed?

RAI therapy is used in two broad situations: treating an overactive thyroid (hyperthyroidism) and treating certain thyroid cancers after surgery.

Hyperthyroidism and Graves’ disease

Hyperthyroidism is the term for a thyroid that produces too much hormone. The most common cause is Graves’ disease, an autoimmune condition in which antibodies stimulate the thyroid to overproduce. For Graves’ disease, the three main treatment paths are antithyroid medication, RAI therapy, and thyroid surgery. The American Thyroid Association describes all three as reasonable options, and the choice depends on the patient’s age, goitre size, severity of symptoms, eye involvement, plans for pregnancy, and personal preference.

Toxic multinodular goitre and toxic adenoma

In toxic multinodular goitre, several thyroid nodules independently produce excess hormone. In toxic adenoma, a single nodule does the same. Both conditions tend to be chronic and rarely settle with antithyroid medication alone. RAI therapy can shrink the overactive nodules and reduce hormone production. Surgery is the other main option.

Differentiated thyroid cancer

After surgery to remove the thyroid (thyroidectomy) for papillary or follicular thyroid cancer — together called differentiated thyroid cancer — small amounts of normal thyroid tissue or microscopic cancer cells may remain. RAI therapy can be used to:

• destroy any thyroid tissue left behind after surgery (called remnant ablation);
• treat known cancer cells in lymph nodes or elsewhere that still absorb iodine; and
• help with long-term monitoring, because once thyroid tissue is gone, a blood marker called thyroglobulin becomes more useful for detecting recurrence.

Not every patient with thyroid cancer needs RAI. Current ATA guidelines describe a risk-based approach: very low-risk cancers may not need it, while higher-risk cancers usually benefit. The decision is made by the treating team after reviewing surgical pathology and imaging.

Recurrent or metastatic thyroid cancer

If differentiated thyroid cancer comes back or spreads, and the cancer cells still take up iodine, RAI therapy may be used again to treat the recurrent or metastatic disease.

Who Is a Candidate?

Whether RAI therapy is appropriate is a clinical decision made by an endocrinologist, often together with a nuclear medicine specialist and, for cancer cases, an endocrine surgeon and oncologist. Several factors are weighed.

Generally considered suitable

• Adults with Graves’ disease who relapse after antithyroid medication, cannot tolerate the medication, or prefer a definitive treatment
• Adults with toxic multinodular goitre or toxic adenoma
• Patients with differentiated thyroid cancer (papillary or follicular) where guidelines support RAI after surgery
• Patients with iodine-avid recurrent or metastatic differentiated thyroid cancer

Generally not suitable

RAI therapy is avoided or postponed in certain situations:

• Pregnancy. Radioactive iodine crosses the placenta and can damage the baby’s developing thyroid. Pregnancy must be excluded before RAI is given, and women of childbearing age have a pregnancy test on the day of treatment.
• Breastfeeding. Radioactive iodine passes into breast milk. Breastfeeding must be stopped well before treatment and is not resumed for the current child.
• Medullary and anaplastic thyroid cancer. These cancers do not absorb iodine, so RAI does not work for them. Different treatments are used.
• Moderate to severe Graves’ eye disease. RAI can worsen thyroid eye disease in some patients. The European Thyroid Association suggests that in patients with active moderate-to-severe eye disease, doctors either avoid RAI or give protective steroid cover; antithyroid medication or surgery may be preferred.
• Very young children. Other treatments are usually tried first (see the section on RAI in children).
• Patients who cannot follow radiation safety precautions. Because brief precautions are required after the dose, patients who cannot reasonably follow them may need a different approach.

Alternatives to RAI Therapy

RAI therapy is one option in a treatment landscape. Knowing the alternatives helps frame the discussion with your doctor.

Antithyroid medication

Medicines such as carbimazole, methimazole, and propylthiouracil (PTU) reduce the thyroid’s production of hormone. They are usually the first treatment for Graves’ disease, especially in younger adults or in pregnancy (PTU in the first trimester, methimazole later). A typical course lasts 12 to 18 months. Some patients stay in remission; others relapse and need definitive treatment.

Thyroid surgery

Removing part or all of the thyroid (thyroidectomy) is a definitive treatment for hyperthyroidism and a necessary first step for thyroid cancer. Surgery is often favoured when a large goitre is causing pressure on the airway or food pipe, when nodules are suspicious for cancer, in some cases of severe Graves’ eye disease, or in pregnancy when medication is not working. Surgery has its own risks, including injury to the parathyroid glands or to the nerves that control the voice.

Beta-blockers

Beta-blockers such as propranolol do not treat the underlying thyroid disease but help control symptoms like a fast heartbeat, tremor, and anxiety while another treatment takes effect.

Active surveillance

For some very low-risk thyroid cancers, surveillance without immediate further treatment is increasingly considered. For benign single nodules that are not overactive, observation may be appropriate.

Each option has trade-offs in terms of speed of effect, likelihood of needing lifelong thyroid hormone tablets afterwards, side effects, and suitability during pregnancy. The choice is individual.

Preparing for RAI Therapy

Preparation matters because it directly affects how much radioactive iodine the thyroid takes up — and therefore how well the treatment works.

Confirming the diagnosis and planning the dose

Before treatment, your team will usually review:

• thyroid function tests (TSH, free T3, free T4);
• thyroid antibody tests for autoimmune disease (TRAb, TPO);
• a thyroid ultrasound;
• a radioactive iodine uptake (RAIU) scan, which measures how much iodine the thyroid is taking up; and
• for cancer patients, a whole-body iodine scan and thyroglobulin levels.

Your medical history, current medicines, and pregnancy status are reviewed. The dose of I-131 is then planned by the nuclear medicine specialist. Doses for benign hyperthyroidism are much lower than doses used after thyroid cancer surgery.

Stopping certain medications

Antithyroid medication (carbimazole, methimazole, PTU) is usually stopped a few days before RAI, because these drugs reduce the thyroid’s ability to absorb iodine. Iodine-containing medicines, iodinated contrast from CT scans, and certain supplements may also need to be stopped weeks in advance.

Low-iodine diet

For thyroid cancer patients especially, a low-iodine diet is usually started one to two weeks before treatment. The point is to make thyroid cells “hungry” for iodine so they absorb the radioactive form more eagerly. Foods generally limited include iodised salt, seafood, seaweed, dairy products, egg yolks, soy products, and bakery items made with iodised salt. Fresh fruits, fresh vegetables, fresh meat in moderation, rice, and home-cooked food without iodised salt are usually allowed. Your team will give you a specific food list.

Raising TSH (for thyroid cancer)

For thyroid cancer treatment, RAI works better when TSH is high, because high TSH drives any remaining thyroid cells to take up iodine. This is achieved either by stopping thyroid hormone tablets for a few weeks (causing temporary hypothyroidism) or by giving injections of recombinant human TSH (rhTSH, also known as Thyrogen) over two days before the dose. The choice depends on availability and clinical factors.

Pregnancy testing and contraception

A pregnancy test is mandatory before treatment for women of childbearing age. Women are advised to avoid pregnancy for a period after treatment — commonly 6 to 12 months — and to discuss timing with their specialist. Men receiving higher doses for cancer are usually advised to delay fathering a child for several months.

Counselling and safety briefing

Before treatment, you will be told what to expect on the day, what radiation safety precautions to follow at home, and how follow-up will be arranged. This is a good time to ask questions about work, travel, and family contact.

What Happens During RAI Therapy

The treatment itself is short and painless. The complexity is in the planning around it.

On the day of treatment

You will usually be asked to come fasting or with only a light meal. The team reviews your blood tests, confirms the pregnancy test if applicable, and checks that you have followed the preparation instructions. You are taken to a designated nuclear medicine area.

The I-131 is given as a capsule that you swallow with water, sometimes as a liquid through a straw. There is no injection, no needle, no anaesthetic. The dose itself takes only a few seconds to take.

After the dose

For benign hyperthyroidism, the dose is usually low enough that you can go home the same day, after a short observation period and a safety briefing. In India, radiation safety is regulated by the Atomic Energy Regulatory Board (AERB), and the rules about whether you go home or stay in a shielded room are based on the activity (dose) given.

For thyroid cancer, doses are typically higher. Many patients spend one to a few nights in a special isolation room in the hospital until the radiation level in their body drops to a level at which it is safe to go home. The room has its own bathroom and is designed to limit the spread of radioactive material. You can usually see family through a window or by phone but not in person until the level falls.

Whole-body scan after treatment

For cancer patients, a whole-body scan is often done several days after the dose. This is because the I-131 you have already received also gives off a small amount of gamma radiation that a scanner can pick up. The scan shows where the iodine has gone — useful information for spotting residual thyroid tissue or disease that has spread.

Recovery and Healing

Unlike surgery, there are no wounds to heal after RAI therapy. The treatment works gradually, over weeks to months, as the radiation destroys abnormal thyroid cells.

The first days

Most of the radioactive iodine that is not absorbed by the thyroid leaves the body through urine within the first one to two days. Smaller amounts leave through saliva, sweat, and stool. You will be asked to drink plenty of fluids to help flush it out, to wash your hands often, to flush the toilet (some centres advise flushing twice), and to keep up good oral hygiene.

To protect the salivary glands, which can absorb a small amount of radioactive iodine, you may be advised to suck on sugar-free sour sweets or chew sugar-free gum to keep saliva flowing, starting a day or so after the dose. Your team will tell you the exact timing, as starting too soon may not be helpful.

Radiation safety precautions at home

Following AERB and hospital guidance, you will be asked to:

• sleep alone for a number of days;
• keep some distance from other adults whenever practical;
• avoid close, prolonged contact with infants, young children, and pregnant women for a longer period;
• use separate towels and wash them separately for the first few days;
• avoid sharing utensils, cups, and toothbrushes;
• wash hands thoroughly after using the toilet; and
• continue to drink plenty of fluids.

The exact duration of these precautions depends on the dose you received and the centre’s protocol. For low-dose treatment of hyperthyroidism, a few days may be enough. For higher cancer doses, precautions may extend to two or three weeks for the most sensitive contacts. Your discharge instructions will list specific timelines.

How quickly the treatment works

You will not feel an instant change. The thyroid’s response unfolds over weeks:

• By two to six weeks, hyperthyroid symptoms often begin to ease, although some patients feel briefly worse first as stored hormone is released.
• By two to six months, the full effect of the treatment usually becomes clear on blood tests.
• For cancer patients, response is assessed using thyroglobulin levels, ultrasound, and sometimes follow-up whole-body scans over the following six to twelve months.

Returning to daily life

Most patients return to work within a few days to two weeks, depending on the dose and on whether work involves close contact with children or pregnant women. Driving, household activities, light exercise, and social interaction can usually be resumed in stages as soon as you feel up to it and the precaution period allows. Air travel within the first weeks should be discussed with your team, as sensitive radiation detectors at airports can pick up residual radioactivity and you may need a letter from your doctor.

Risks and Complications

RAI therapy has been studied for decades and has a strong safety record. Most side effects are temporary. A smaller number are long-term.

Short-term side effects

• Neck tenderness or mild swelling a few days after the dose, due to inflammation of the thyroid (radiation thyroiditis). This usually settles with simple pain relief.
• Temporary worsening of hyperthyroid symptoms in the first one to two weeks as stored hormone is released from damaged cells. Beta-blockers can help.
• Salivary gland tenderness or swelling, dry mouth, and a metallic taste, because the salivary glands absorb a small amount of I-131.
• Nausea for a day or two after swallowing the capsule.
• Fatigue, often more pronounced for cancer patients who have been off thyroid hormone before treatment.

Long-term effects

• Hypothyroidism (underactive thyroid). This is the most common long-term outcome and is often expected. As thyroid tissue is destroyed, the gland makes less hormone, and most patients eventually need a daily thyroid hormone tablet (levothyroxine) for life. For thyroid cancer treatment, hypothyroidism is universal because the gland has already been removed; levothyroxine is started routinely.
• Persistent dry mouth and dental problems. A minority of patients, particularly after higher cancer doses, develop ongoing dry mouth, which can increase the risk of dental cavities. Good dental care and regular check-ups help.
• Dry eyes in a small number of patients.
• Worsening of Graves’ eye disease. RAI can trigger or worsen thyroid eye disease in some patients with Graves’, especially smokers. Doctors may give steroid cover, or prefer a different treatment, when active eye disease is present.
• Fertility. Temporary effects on sperm production can occur after high cancer doses; permanent infertility is uncommon. Effects on female fertility are generally minimal at typical doses. Pregnancy is delayed for a period after treatment as a precaution.
• Risk of second cancers. Large studies suggest the risk of developing a second cancer after standard RAI doses is small. The risk is dose-related and is one reason higher cumulative doses are avoided when not needed.

When to contact your doctor

After RAI therapy, contact your healthcare team if you develop:

• severe neck pain, swelling, or difficulty breathing or swallowing;
• a high fever or signs of infection;
• persistent vomiting or inability to keep fluids down;
• chest pain or a very fast or irregular heartbeat;
• new or worsening eye pain, double vision, or vision changes;
• severe or persistent dry mouth or salivary gland pain; or
• symptoms of an underactive thyroid (tiredness, weight gain, cold intolerance, constipation, low mood, slow heart rate) once enough time has passed for these to develop.

Life After RAI Therapy

For most people, life after RAI is straightforward once thyroid hormone levels are stable.

Thyroid hormone replacement

If your thyroid becomes underactive — which is expected for many hyperthyroidism patients and universal after thyroid cancer treatment — you will be prescribed levothyroxine. It is a tablet taken once a day, usually first thing in the morning on an empty stomach, with water, at least 30 to 60 minutes before food and other medicines. Calcium and iron supplements should be taken several hours apart from levothyroxine, because they can reduce absorption.

The dose is adjusted based on TSH blood tests. For hyperthyroidism patients, the goal is usually a normal TSH. For thyroid cancer patients, the doctor may aim for a TSH at the lower end of normal or even slightly suppressed, depending on the cancer’s risk category, because thyroid cancer cells can be stimulated by TSH.

Follow-up

For benign hyperthyroidism, follow-up typically involves thyroid function tests at intervals (commonly 4 to 8 weeks initially, then less often) until levels are stable, and then long-term checks at least once or twice a year. If hyperthyroidism persists three to six months after treatment, a second dose of RAI may be considered.

For differentiated thyroid cancer, follow-up is lifelong. It usually includes regular thyroglobulin and thyroglobulin antibody blood tests, neck ultrasound, and sometimes further imaging. Most patients with low- and intermediate-risk thyroid cancer remain disease-free.

Diet, exercise, and lifestyle

Once the post-treatment dietary restrictions are over, you can return to a balanced diet. Iodised salt and seafood are not banned long-term unless your doctor advises otherwise. Smoking is best avoided, particularly for patients with Graves’ eye disease, as smoking worsens it. Regular exercise, adequate sleep, and stress management support overall recovery.

Pregnancy and family planning

Most patients who want to have children can do so after RAI therapy, once the recommended waiting period has passed and thyroid hormone levels are stable. Tell your obstetrician about your history; you may need closer thyroid monitoring during pregnancy, and levothyroxine doses often need to be increased.

Emotional well-being

Thyroid disease and its treatment affect mood, energy, and confidence. Some patients feel anxious about radiation, about hypothyroidism, about lifelong medication, or about cancer recurrence. These feelings are common. Talking to your team, to family, or to a counsellor, and connecting with patient support groups, can help.

Radioactive Iodine Therapy in Children

RAI therapy is used in children, but with extra caution. For children with Graves’ disease, antithyroid medication is usually the first treatment, often continued for longer courses than in adults. If medication does not control the disease or causes side effects, RAI or surgery is considered.

Major guidelines (including those of the American Thyroid Association) generally suggest avoiding RAI in very young children and using higher, ablative doses rather than low doses when RAI is given to children, because incomplete treatment with a small dose is thought to leave more residual at-risk tissue. Decisions are made by paediatric endocrinologists with experience in thyroid disease, balancing disease control, long-term risks, and family preferences.

Differentiated thyroid cancer is rare in children but tends to present with more advanced neck disease and lung spread. Children with thyroid cancer that takes up iodine may receive RAI after surgery, planned carefully with paediatric specialists.

Hypothyroidism after treatment is expected and is managed with levothyroxine adjusted to growth, weight, and pubertal stage.

Frequently Asked Questions

Is RAI therapy painful?

The dose itself is painless. You swallow a capsule or liquid. Some people have mild neck or salivary gland tenderness in the days afterwards, which usually settles with simple pain relief.

Will I be radioactive forever?

No. Iodine-131 has a physical half-life of about eight days, meaning the radioactivity halves roughly every eight days. Most of the dose that is not absorbed by the thyroid leaves the body through urine in the first one to two days. Radiation safety precautions are needed for days to a few weeks, depending on the dose.

Is RAI therapy the same as chemotherapy?

No. Chemotherapy uses drugs that act on cells throughout the body. RAI therapy targets thyroid cells specifically because they are the cells that absorb iodine. The side effect profile is very different.

Will I lose my hair?

Hair loss is uncommon with RAI. The hair changes some patients notice tend to be related to thyroid hormone changes (hyperthyroidism or hypothyroidism), not to the radiation itself.

Will I need lifelong medication?

Many hyperthyroidism patients eventually need levothyroxine because the thyroid becomes underactive. All thyroid cancer patients treated with thyroidectomy need it. Levothyroxine is a straightforward daily tablet, and once the dose is right, most people feel well.

Can I be around my family after treatment?

Yes, with brief precautions. You will be advised on how much distance to keep, for how long, and which contacts (infants, young children, pregnant women) need more caution. Routine activities with adult family members are usually possible within a short period, especially after low-dose treatment.

Can I have children after RAI therapy?

Most patients retain normal fertility. Pregnancy is delayed for the period your specialist advises, commonly 6 to 12 months for women after cancer treatment. Men receiving higher doses may be advised to delay fathering a child for several months.

Can hyperthyroidism come back?

Most patients are well controlled after one dose. A minority need a second dose. If hyperthyroidism is not settling within several months, your endocrinologist will reassess.

How quickly will I feel better?

For hyperthyroidism, symptoms usually start to improve over weeks, with the full effect over several months. Beta-blockers may be used to control symptoms in the meantime.

Does RAI therapy cure thyroid cancer?

RAI is one part of treatment for differentiated thyroid cancer, used together with surgery and long-term TSH-managed thyroid hormone replacement. In appropriately selected patients, the combination is associated with very good long-term outcomes. Your doctor can give you a personalised picture based on your pathology and imaging.

Will I need long-term follow-up?

Yes. Lifelong follow-up of thyroid hormone levels is part of life after RAI. Thyroid cancer patients also need long-term cancer surveillance.

Conclusion

Radioactive iodine therapy is a precise, well-established treatment that uses the thyroid’s natural appetite for iodine to act selectively on abnormal thyroid cells. It is one of several options for hyperthyroidism, Graves’ disease, and toxic nodules, and it has a defined role in the management of differentiated thyroid cancer after surgery.

The treatment itself is short and painless, but the planning around it — preparation, dose selection, radiation safety, and long-term follow-up — matters. Most patients recover well, return to normal life within days to weeks, and need only a daily thyroid hormone tablet and regular check-ups in the long term. Whether RAI is the right next step for you is a decision to make with your endocrinologist and, where relevant, your thyroid cancer team, after weighing the alternatives and your personal circumstances.